. Author manuscript; available in PMC: 2023 Jul 1.

Published in final edited form as: Vox Sang. 2022 Mar 17;117(7):920–928. doi: 10.1111/vox.13270

Table 3:

Deferral rate and HIV status is accepted and deferred blood donors

Donor screening approach	Deferral rate n(%)	HIV in Accepted n(%)	HIV in Deferred n(%)	Sens/Spec (%)	AUC
Routine questionnaire alone (n=10,918)^π	2,611 (23.9)	7 (0.6)	29 (0.2)	40.8/76.6
RDT alone (pre-test) (n=10,106)^µ	202 (2.0)	0 (0)	64 (0.6)	100/98.1
Routine questionnaire + RDT (pre-test) (n=10,106)^µ	2,801(25.2)	0 (0)	64 (0.6)	100/72.0
ASDHQ cut-off 82.2^* (n=11,120)	46 (0.4)	71 (0.6)	0 (0)	0/100
ASDHQ cut-off 95.04 (n=11,120)	4,806 (43.1)	34 (0.7)	37 (0.6)	57/53	0.58 [0.51, 0.64] p=0.028

Tagny & al, 2012,

^π

All sites,

^µ

HCY+HRB